Skip to main content

Table 2 Patient characteristics

From: The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility

VariableBaseline value (N = 204)
Age, years, mean (SD)70.5 (10.9)
Sex, n (%)
 Male138 (67.6)
 Female66 (32.4)
Type of MI, n (%)
 NSTEMI127 (62.3)
 STEMI77 (37.7)
SPM, n (%)
 Aspirin190 (93.1)
 Other antiplatelet agent192 (94.1)
 Ticagrelor (twice daily)159 (77.9)
 ACE inhibitor / ARB188 (92.2)
  Twice daily dosing44 (21.6)
 Beta-blocker180 (88.2)
  Twice daily dosing23 (11.3)
 Statin192 (94.1)
SPM administration times,* n (%)
 One regular administration time per day5 (2.5)
 Two regular administration times per day147 (72.1)
 Three regular administration times per day40 (19.6)
 Not completed12 (5.9)
  1. N = 204. *The total number of times the patient had to take a medicine, regardless of the number of medicines taken at the point of administration (i.e. more than one medicine may have been taken at each administration time). ACE Angiotensin converting enzyme, ARB Angiotensin II receptor blocker, NSTEMI non-ST-elevation myocardial infarction, MI Myocardial infarction, SD Standard deviation, SPM Secondary prevention medicine, STEMI ST-elevation myocardial infarction